Document is current

Article History

Received: 20 February 2019

Accepted: 9 September 2019

First Online: 9 December 2019

Ethics approval and consent to participate

: This study was approved by the Ottawa Health Science Network–Research Ethics Board (OHSN-REB #20160408) and is the principal study site. Relevant amendments to the protocol will be submitted to the ethics committee for further approval as warranted.All participants will be given detailed oral and written information about the trial. Consent forms describing the study intervention, study procedures, and risks will be given to each participant and written documentation of informed consent will be required prior to starting study intervention (Additional file ). Each participant should have sufficient opportunity to discuss the study and consider the information in the consent process prior to agreeing to participate. Informed consent will be obtained by the recruiting physician.Participants may withdraw consent at any time during the course of the trial. The informed consent form will be signed and dated by the participant and the person who conducts the informed consent discussion. The original signed informed consent form will be stored separately from the patient’s de-identified data and a copy of the signed form will be provided to the participant.Study participants will not receive any monetary compensation to participate in this trial.

: Not applicable.

: The authors declare that they have no competing interests.